Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.

被引：0
|
作者：
Hammer, Liat
Rebernick, Ryan
McFarlane, Matthew
Westbrook, Thomas
Hazime, Munna
Hammoud, Tanya
Chiu, Pin-en
Xavier, Owens
Wu, Yi-Mi
Robinson, Dan R.
Spratt, Daniel Eidelberg
Alva, Ajjai Shivaram
Jackson, William C.
Reichert, Zachery R.
Alumkal, Joshi J.
Chinnaiyan, Arul
Cieslik, Marcin
Dess, Robert Timothy
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA
[3] Univ Michigan, Div Hematol & Oncol, Dept Internal Med, Ann Arbor, MI USA
[4] Univ Michigan, Canc Ctr, Ann Arbor, MI USA
[5] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[6] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[7] Michigan Med, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
263
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer
    Mu, Ping
    Cao, Zhen
    Hoover, Elizabeth
    Wongvipat, John
    Huang, Chun-Hao
    Karthaus, Wouter
    Abida, Wassim
    De Stanchina, Elise
    Sawyers, Charles
    CANCER RESEARCH, 2015, 75
  • [2] RB1 AND TP53 LOSS PROMOTES LINEAGE PLASTICITY IN PROSTATE CANCER
    不详
    CANCER DISCOVERY, 2017, 7 (03) : 244 - 244
  • [3] A Pan-Cancer Assessment of RB1/TP53 Co-Mutations
    Cai, Ling
    DeBerardinis, Ralph J.
    Xiao, Guanghua
    Minna, John D.
    Xie, Yang
    CANCERS, 2022, 14 (17)
  • [4] TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients
    Pandey, Ritu
    Johnson, Nathan
    Cooke, Laurence
    Johnson, Benny
    Chen, Yuliang
    Pandey, Manjari
    Chandler, Jason
    Mahadevan, Daruka
    CANCERS, 2021, 13 (04) : 1 - 21
  • [5] Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers with Concurrent TP53 and RB1 Mutations
    Offin, M.
    Tenet, M.
    Shen, R.
    Rekhtman, N.
    Rizvi, H.
    Hellmann, M.
    Arcila, M.
    Ladanyi, M.
    Rudin, C.
    Kris, M.
    Yu, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S412 - S412
  • [6] Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer
    Humid, Anis A.
    Gray, Kathryn P.
    Shaw, Grace
    MacConaill, Laura E.
    Evan, Carolyn
    Bernard, Brandon
    Loda, Massimo
    Corcoran, Niall M.
    Van Allen, Eliezer M.
    Choudhury, Atish D.
    Sweeney, Christopher J.
    EUROPEAN UROLOGY, 2019, 76 (01) : 89 - 97
  • [7] Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma
    Yongyang Bao
    J.Eva Selfridge
    Janet Wang
    Yiqing Zhao
    Junqi Cui
    Kishore Guda
    Zhenghe Wang
    Yanbo Zhu
    Journal of Genetics and Genomics, 2019, 46 (06) : 315 - 318
  • [8] Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma
    Bao, Yongyang
    Selfridge, J. Eva
    Wang, Janet
    Zhao, Yiqing
    Cui, Junqi
    Guda, Kishore
    Wang, Zhenghe
    Zhu, Yanbo
    JOURNAL OF GENETICS AND GENOMICS, 2019, 46 (06) : 315 - 318
  • [9] Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53
    Ueki, Hideto
    Jimbo, Naoe
    Terakawa, Tomoaki
    Hara, Takuto
    Tobe, Taisuke
    Hirata, Junichiro
    Wakita, Naoto
    Okamura, Yasuyoshi
    Suzuki, Kotaro
    Bando, Yukari
    Chiba, Koji
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    PROSTATE, 2024, 84 (16): : 1506 - 1514
  • [10] Cigarette smoking and TP53 mutations in bladder cancer.
    Zhang, ZF
    Lu, ML
    Cordon-Cardo, C
    Shu, XM
    Cao, PQ
    Connolly-Jenks, C
    Dalbagni, G
    Reuter, VE
    Scher, H
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 149 (11) : S66 - S66
12345